Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-17 | Neumora Therapeutics, Inc. | Fust Matthew K
(Director) |
S | Common Stock | D | 21788 | $17.01 - $17.03 | $370,961 |
| 2024-10-17 | Neumora Therapeutics, Inc. | Fust Matthew K
(Director) |
M | Common Stock | A | 21788 | $2.52 - $8.79 | $127,035 |
| 2024-09-17 | Neumora Therapeutics, Inc. | Lenz Robert A.
(Head of R&D) |
S | Common Stock | D | 41464 | $11.81 - $12.09 | $492,825 |
| 2024-09-12 | Neumora Therapeutics, Inc. | Lenz Robert A.
(Head of R&D) |
S | Common Stock | D | 32948 | $11.43 - $11.43 | $376,664 |
| 2024-08-27 | Neumora Therapeutics, Inc. | Pinto Joshua
(Chief Financial Officer) |
S | Common Stock | D | 15693 | $11.39 - $11.39 | $178,806 |
| 2024-08-22 | Neumora Therapeutics, Inc. | Pinto Joshua
(Chief Financial Officer) |
S | Common Stock | D | 84307 | $11.59 - $11.78 | $984,060 |
| 2024-04-17 | Neumora Therapeutics, Inc. | Pinto Joshua
(Chief Financial Officer) |
G | Common Stock | D | 238965 | $0.00 - $0.00 | $0 |
| 2024-06-13 | Neumora Therapeutics, Inc. | Ho Maykin
(Director) |
A | Common Stock | A | 20100 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |